NI
IBRX icon

Numeric Investors’s ImmunityBio IBRX Stock Holding History

Numeric Investors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,100
Closed -$139K – 1046
2015
Q3 		$139K Buy
+12,100
New +$264K ﹤0.01% 943

Other funds holding IBRX

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Numeric Investors's IBRX Position: Q4 2015 in Review

Numeric Investors sold out of ImmunityBio (IBRX) in Q4 2015, closing a stake of 12,100 shares — an estimated $139K sold.

Numeric Investors first reported a position in IBRX in Q3 2015 and held it in 1 quarter. The position peaked at $139K in Q3 2015. 61 funds tracked by Wall St. Rank hold IBRX as of Q4 2015.

  • Numeric Investors reported no remaining ImmunityBio position as of Q4 2015 after selling out during the quarter.
  • Numeric Investors sold 12,100 ImmunityBio shares in Q4 2015, an estimated $139K.
  • Numeric Investors first reported a position in ImmunityBio in Q3 2015 and held it in 1 quarter.
  • Numeric Investors's ImmunityBio position peaked at $139K in Q3 2015.
  • 61 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2015.

Based on Numeric Investors's 13F filing for Q4 2015, filed 1 Feb 2016.